Skip to content

Nonfunctioning adrenal masses were linked to less favorable cardiovascular risk markers

A pooled analysis found differences in artery and metabolic measurements, but the abstract gives no results for cardiovascular events.

By 100HP editorialAbstract-based explanation checked

Based on the published abstract. The full paper may contain additional methods, results and limitations.

The 30-second takeaway

People with adrenal masses classified as nonfunctioning had less favorable cardiovascular and metabolic markers than matched people without adrenal masses. The review links these masses with thicker carotid artery walls and greater insulin resistance. It does not establish that the masses cause cardiovascular disease or quantify future heart attacks or strokes.

Keep in mind

The abstract reports surrogate measurements, without cardiovascular event results or follow-up duration. This abstract-based brief cannot assess how differences between the groups might have influenced the pooled estimates.

THE NUMBERS, WITH CONTEXT

What researchers found

1.22

Carotid artery wall thickness: standardized mean difference

Higher with nonfunctioning adrenal masses than in matched people without adrenal masses; 95% CI 0.87–1.58. Assessment timing was not reported in the abstract.

J Clin Endocrinol Metab, 2026 · Original source ↓

What the review measured

The main outcomes were carotid artery wall thickness and insulin resistance. Additional analyses examined other vascular measurements and a heart muscle mass index. These markers describe aspects of cardiovascular health without directly counting cardiovascular illness.

What the difference means

The pooled difference of 1.22 means carotid wall thickness averaged 1.22 standard deviations higher in people with nonfunctioning adrenal masses than in controls. A standard deviation describes variation among participants' measurements. This scale is neither millimeters nor percentage change in disease risk.

CHECK THE ORIGINAL

The original publication

Cardiometabolic Risk Parameters in "Nonfunctioning" Adrenal Incidentalomas: A Systematic Review and Meta-analysis.

Favero V, Bernasconi D, Maloberti A et al.
J Clin Endocrinol Metab · 2026

PubMed ID
41165151
Record checked

AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.